Readystate Asset Management LP Akero Therapeutics, Inc. Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
A detailed history of Readystate Asset Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 640,923 shares of AKRO stock, worth $29.5 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
640,923
Previous 100,500
537.73%
Holding current value
$29.5 Million
Previous $4.07 Billion
740.65%
% of portfolio
1.05%
Previous 0.14%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
296Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$310 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$264 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$257 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$252 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$209 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.14B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...